These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 34242679)
1. Urotensin II induces activation of NLRP3 and pyroptosis through calcineurin in cardiomyocytes. Liang Y; Wu X; Xu M; Ding L; Li H; Wu Y Peptides; 2021 Oct; 144():170609. PubMed ID: 34242679 [TBL] [Abstract][Full Text] [Related]
2. Urotensin II induction of neonatal cardiomyocyte hypertrophy involves the CaMKII/PLN/SERCA 2a signaling pathway. Shi H; Han Q; Xu J; Liu W; Chu T; Zhao L Gene; 2016 May; 583(1):8-14. PubMed ID: 26930364 [TBL] [Abstract][Full Text] [Related]
3. Doxorubicin induces cardiomyocyte pyroptosis via the TINCR-mediated posttranscriptional stabilization of NLR family pyrin domain containing 3. Meng L; Lin H; Zhang J; Lin N; Sun Z; Gao F; Luo H; Ni T; Luo W; Chi J; Guo H J Mol Cell Cardiol; 2019 Nov; 136():15-26. PubMed ID: 31445005 [TBL] [Abstract][Full Text] [Related]
4. Direct actions of urotensin II on the heart: implications for cardiac fibrosis and hypertrophy. Tzanidis A; Hannan RD; Thomas WG; Onan D; Autelitano DJ; See F; Kelly DJ; Gilbert RE; Krum H Circ Res; 2003 Aug; 93(3):246-53. PubMed ID: 12842917 [TBL] [Abstract][Full Text] [Related]
5. Expression of urotensin II is positively correlated with pyroptosis-related molecules in patients with severe preeclampsia. Pan YJ; Zhang MZ; He LH; Feng J; Zhang AH Clin Exp Hypertens; 2021 Apr; 43(3):295-304. PubMed ID: 33371762 [No Abstract] [Full Text] [Related]
6. Urotensin II Protects Cardiomyocytes from Apoptosis Induced by Oxidative Stress through the CSE/H2S Pathway. Gong H; Chen Z; Zhang X; Li Y; Zhang J; Chen Y; Ding Y; Zhang G; Yang C; Zhu Y; Zou Y Int J Mol Sci; 2015 Jun; 16(6):12482-98. PubMed ID: 26047336 [TBL] [Abstract][Full Text] [Related]
7. Osteopontin is involved in urotensin II-induced migration of rat aortic adventitial fibroblasts. Zhang YG; Kuang ZJ; Mao YY; Wei RH; Bao SL; Wu LB; Li YG; Tang CS Peptides; 2011 Dec; 32(12):2452-8. PubMed ID: 22036853 [TBL] [Abstract][Full Text] [Related]
8. Role of PKA in the process of neonatal cardiomyocyte hypertrophy induced by urotensin II. Xu J; Han Q; Shi H; Liu W; Chu T; Li H Int J Mol Med; 2017 Aug; 40(2):499-504. PubMed ID: 28656205 [TBL] [Abstract][Full Text] [Related]
9. Urotensin II induction of adult cardiomyocytes hypertrophy involves the Akt/GSK-3beta signaling pathway. Gruson D; Ginion A; Decroly N; Lause P; Vanoverschelde JL; Ketelslegers JM; Bertrand L; Thissen JP Peptides; 2010 Jul; 31(7):1326-33. PubMed ID: 20416349 [TBL] [Abstract][Full Text] [Related]
10. Astragaloside IV alleviates renal fibrosis by inhibiting renal tubular epithelial cell pyroptosis induced by urotensin II through regulating the cAMP/PKA signaling pathway. Zhang L; Liu W; Li S; Wang J; Sun D; Li H; Zhang Z; Hu Y; Fang J PLoS One; 2024; 19(5):e0304365. PubMed ID: 38820434 [TBL] [Abstract][Full Text] [Related]
11. Urotensin II receptor antagonist attenuates monocrotaline-induced cardiac hypertrophy in rats. Gao S; Oh YB; Shah A; Park WH; Chung MJ; Lee YH; Kim SH Am J Physiol Heart Circ Physiol; 2010 Dec; 299(6):H1782-9. PubMed ID: 20870804 [TBL] [Abstract][Full Text] [Related]
12. NF-κB-Gasdermin D (GSDMD) Axis Couples Oxidative Stress and NACHT, LRR and PYD Domains-Containing Protein 3 (NLRP3) Inflammasome-Mediated Cardiomyocyte Pyroptosis Following Myocardial Infarction. Lei Q; Yi T; Chen C Med Sci Monit; 2018 Aug; 24():6044-6052. PubMed ID: 30161099 [TBL] [Abstract][Full Text] [Related]
13. A novel role of G protein-coupled receptor kinase 5 in urotensin II-stimulated cellular hypertrophy in H9c2 Park CH; Lee JH; Lee MY; Lee JH; Lee BH; Oh KS Mol Cell Biochem; 2016 Nov; 422(1-2):151-160. PubMed ID: 27613164 [TBL] [Abstract][Full Text] [Related]
14. Lipopolysaccharide (LPS) Aggravates High Glucose- and Hypoxia/Reoxygenation-Induced Injury through Activating ROS-Dependent NLRP3 Inflammasome-Mediated Pyroptosis in H9C2 Cardiomyocytes. Qiu Z; He Y; Ming H; Lei S; Leng Y; Xia ZY J Diabetes Res; 2019; 2019():8151836. PubMed ID: 30911553 [TBL] [Abstract][Full Text] [Related]
15. Angiotensin II and the JNK pathway mediate urotensin II expression in response to hypoxia in rat cardiomyocytes. Chiu CZ; Wang BW; Shyu KG J Endocrinol; 2014 Mar; 220(3):233-46. PubMed ID: 24481965 [TBL] [Abstract][Full Text] [Related]
16. Amentoflavone mitigates doxorubicin-induced cardiotoxicity by suppressing cardiomyocyte pyroptosis and inflammation through inhibition of the STING/NLRP3 signalling pathway. Fang G; Li X; Yang F; Huang T; Qiu C; Peng K; Wang Z; Yang Y; Lan C Phytomedicine; 2023 Aug; 117():154922. PubMed ID: 37321078 [TBL] [Abstract][Full Text] [Related]
17. Cardioprotective effect of cinnamaldehyde pretreatment on ischemia/ reperfusion injury via inhibiting NLRP3 inflammasome activation and gasdermin D mediated cardiomyocyte pyroptosis. Luan F; Lei Z; Peng X; Chen L; Peng L; Liu Y; Rao Z; Yang R; Zeng N Chem Biol Interact; 2022 Dec; 368():110245. PubMed ID: 36341777 [TBL] [Abstract][Full Text] [Related]
18. Urotensin-II receptor blockade with SB-611812 attenuates cardiac remodeling in experimental ischemic heart disease. Bousette N; Pottinger J; Ramli W; Ohlstein EH; Dhanak D; Douglas SA; Giaid A Peptides; 2006 Nov; 27(11):2919-26. PubMed ID: 16919371 [TBL] [Abstract][Full Text] [Related]
19. MCC950 attenuates doxorubicin-induced myocardial injury in vivo and in vitro by inhibiting NLRP3-mediated pyroptosis. Zhang L; Jiang YH; Fan C; Zhang Q; Jiang YH; Li Y; Xue YT Biomed Pharmacother; 2021 Nov; 143():112133. PubMed ID: 34474337 [TBL] [Abstract][Full Text] [Related]
20. RyR2 Stabilizer Attenuates Cardiac Hypertrophy by Downregulating TNF-α/NF-κB/NLRP3 Signaling Pathway through Inhibiting Calcineurin. Gao Y; Li S; Liu X; Si D; Chen W; Yang F; Sun H; Yang P J Cardiovasc Transl Res; 2024 Jun; 17(3):481-495. PubMed ID: 38652413 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]